COINBASE GLOBAL, INC. Issuer AND U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, Trustee INDENTURE Dated as of , 20 Debt SecuritiesIndenture • May 8th, 2025 • Coinbase Global, Inc. • Finance services • New York
INDENTURE, dated as of , 20 , among Coinbase Global, Inc., a Delaware corporation (the “Company”), and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”):
GOLDEN MATRIX GROUP, INC., Issuer AND Trustee INDENTURE Dated as of [●], 20[●] Debt Securities INDENTUREIndenture • May 2nd, 2025 • Golden Matrix Group, Inc. • Services-prepackaged software • New York
WHEREAS, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;
Protalix BioTherapeutics, Inc., Issuer AND Trustee INDENTURE Dated as of _____ ___, 202_ CROSS-REFERENCE TABLE*Indenture • April 28th, 2025 • Protalix BioTherapeutics, Inc. • Biological products, (no disgnostic substances) • New York
*This Cross-Reference Table does not constitute part of the Indenture and shall not have any bearing on the interpretation of any of its terms or provisions.
Protalix BioTherapeutics, Inc., Issuer AND Trustee INDENTURE Dated as of _____ ___, 202_ CROSS-REFERENCE TABLE*Indenture • April 28th, 2025 • Protalix BioTherapeutics, Inc. • Biological products, (no disgnostic substances) • New York
*This Cross-Reference Table does not constitute part of the Indenture and shall not have any bearing on the interpretation of any of its terms or provisions.
ESPERION THERAPEUTICS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [●], 202[●] Senior Debt SecuritiesIndenture • April 18th, 2025 • Esperion Therapeutics, Inc. • Pharmaceutical preparations • New York
INDENTURE, dated as of [●], 202[●] , among ESPERION THERAPEUTICS, INC., a Delaware corporation (the “Company”), and [TRUSTEE] as trustee (the “Trustee”):
ESPERION THERAPEUTICS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [·], 202[·] Subordinated Debt SecuritiesIndenture • April 18th, 2025 • Esperion Therapeutics, Inc. • Pharmaceutical preparations • New York
INDENTURE, dated as of [·], 202[·] , among ESPERION THERAPEUTICS, INC., a Delaware corporation (the “Company”), and [TRUSTEE] as trustee (the “Trustee”):
SEMLER SCIENTIFIC, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [·], 202[·] Senior Debt SecuritiesIndenture • April 15th, 2025 • Semler Scientific, Inc. • Electromedical & electrotherapeutic apparatus • New York
INDENTURE, dated as of [·], 202[·] , among SEMLER SCIENTIFIC, INC., a Delaware corporation (the “Company”), and [TRUSTEE] as trustee (the “Trustee”):
SEMLER SCIENTIFIC, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [●], 202[●] Subordinated Debt SecuritiesIndenture • April 15th, 2025 • Semler Scientific, Inc. • Electromedical & electrotherapeutic apparatus • New York
INDENTURE, dated as of [●], 202[●] , among SEMLER SCIENTIFIC, INC., a Delaware corporation (the “Company”), and [TRUSTEE] as trustee (the “Trustee”):
SERINA THERAPEUTICS, INC. Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [ ] Senior Debt SecuritiesIndenture • April 2nd, 2025 • Serina Therapeutics, Inc. • Pharmaceutical preparations • New York
INDENTURE, dated as of [ ], among SERINA THERAPEUTICS, INC., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
SERINA THERAPEUTICS, INC. Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [ ] Subordinated Debt SecuritiesIndenture • April 2nd, 2025 • Serina Therapeutics, Inc. • Pharmaceutical preparations • New York
INDENTURE, dated as of [ ], among SERINA THERAPEUTICS, INC., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
PACIFICORP AND THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee Indenture Dated as of March 20, 2025 Subordinated Debt SecuritiesIndenture • March 20th, 2025 • Pacificorp /Or/ • Electric services • New York
INDENTURE, dated as of March 20, 2025, between PACIFICORP, a corporation duly organized and existing under the laws of the State of Oregon (herein called the “Company”), having its principal office at 825 N.E. Multnomah Street, Suite 2000, Portland, Oregon 97232, and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., a national banking association duly organized and existing under the laws of the United States, as Trustee (herein called the “Trustee”).
MONTE ROSA THERAPEUTICS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [●], 202[●] Subordinated Debt SecuritiesIndenture • March 20th, 2025 • Monte Rosa Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
MONTE ROSA THERAPEUTICS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 202[•] Senior Debt SecuritiesIndenture • March 20th, 2025 • Monte Rosa Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
ASANA, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of __, 20__ Debt SecuritiesIndenture • March 18th, 2025 • Asana, Inc. • Services-prepackaged software • New York
COMSTOCK INC. INDENTURE Dated as of DEBT SECURITIES TrusteeIndenture • March 12th, 2025 • Comstock Inc. • Industrial organic chemicals • New York
WHEREAS, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of unsecured debentures, notes, bonds or other evidences of indebtedness (the “Securities”) in an unlimited aggregate principal amount to be issued from time to time in one or more series as provided in this Indenture; and
ROCKET LAB USA, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 202[•] Subordinated Debt SecuritiesIndenture • March 11th, 2025 • Rocket Lab USA, Inc. • Guided missiles & space vehicles & parts • New York
WHEREAS, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of subordinated debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;
VERRICA PHARMACEUTICALS INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 20__ Debt SecuritiesIndenture • March 11th, 2025 • Verrica Pharmaceuticals Inc. • Pharmaceutical preparations • New York
INDENTURE, dated as of [•], 20__, among VERRICA PHARMACEUTICALS INC., a Delaware corporation (the “Company”), and[TRUSTEE], as trustee (the “Trustee”):
OHMYHOME LIMITED (the “Issuer”) AND [TRUSTEE] (the “Trustee”) INDENTURE Dated as of March 7, 2025 Senior Debt SecuritiesIndenture • March 7th, 2025 • Ohmyhome LTD • Real estate agents & managers (for others) • New York
INDENTURE, dated as of [●], 2025, among OHMYHOME LIMITED , a Cayman Islands corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”).
TSCAN THERAPEUTICS, INC. Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 202[•] Subordinated Debt SecuritiesIndenture • March 5th, 2025 • TScan Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
INDENTURE, dated as of [•], 202 , among TSCAN THERAPEUTICS, INC., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
CYTOKINETICS, INCORPORATED AND _____________, AS TRUSTEE FORM OF INDENTURE DATED AS OF __________ Debt SecuritiesIndenture • February 27th, 2025 • Cytokinetics Inc • Pharmaceutical preparations • New York
THIS INDENTURE, dated as of [•], between CYTOKINETICS, INCORPORATED, a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
JERASH HOLDINGS (US), INC. (the “Issuer”) AND [TRUSTEE] (the “Trustee”) INDENTURE Dated as of [●], 20[●] Subordinated Debt SecuritiesIndenture • February 24th, 2025 • Jerash Holdings (US), Inc. • Apparel & other finishd prods of fabrics & similar matl • New York
INDENTURE, dated as of [●], 20[●], among Jerash Holdings (US), Inc., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”).
JERASH HOLDINGS (US), INC. (the “Issuer”) AND [TRUSTEE] (the “Trustee”) INDENTURE Dated as of [●], 20[●] Senior Debt SecuritiesIndenture • February 24th, 2025 • Jerash Holdings (US), Inc. • Apparel & other finishd prods of fabrics & similar matl • New York
INDENTURE, dated as of [●], 20[●], among Jerash Holdings (US), Inc., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”).
APTEVO THERAPEUTICS INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 20__ Debt SecuritiesIndenture • February 14th, 2025 • Aptevo Therapeutics Inc. • Pharmaceutical preparations • New York
ADS-TEC ENERGY PLC, As Issuer, AND As Trustee INDENTURE DATED AS OF [__________] [___], 20[__] SUBORDINATED DEBT SECURITIES CROSS-REFERENCE TABLE (1)1Indenture • February 12th, 2025 • Ads-Tec Energy Public LTD Co • Miscellaneous transportation equipment
INDENTURE, dated as of [__________] [___], 20[__], between ADS-TEC Energy PLC, a public company incorporated in Ireland (the “Company”), and [_____________], a [_____________], as trustee (the “Trustee”):
ADS-TEC ENERGY PLC, As Issuer, AND As Trustee INDENTURE DATED AS OF [__________] [___], 20[__] SENIOR DEBT SECURITIES CROSS-REFERENCE TABLE1Indenture • February 12th, 2025 • Ads-Tec Energy Public LTD Co • Miscellaneous transportation equipment
INDENTURE, dated as of [__________] [___], 20[_], between ADS-TEC Energy PLC, a public company incorporated in Ireland (the “Company”), and [_____________], a [______________], as trustee (the “Trustee”):
RESEARCH SOLUTIONS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [●], 20__ DEBT SECURITIESIndenture • February 11th, 2025 • Research Solutions, Inc. • Services-business services, nec • New York
INDENTURE, dated as of [●], [●], among Research Solutions, Inc., a Nevada corporation (the “Company”), and [Trustee], as trustee (the “Trustee”):
INDENTURE BY AND BETWEEN FAT BRANDS INC. AND AS TRUSTEE DATED AS OF , 20 SUBORDINATED DEBT SECURITIES (Issuable in Series) ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATIONIndenture • February 6th, 2025 • Fat Brands, Inc • Retail-eating places • New York
INDENTURE, dated as of , between FAT BRANDS INC., a Delaware corporation (the “Company”), having its principal office at , and , as trustee, (the “Trustee”), the office of the Trustee at which at the date hereof its corporate trust business is principally administered being.
KEZAR LIFE SCIENCES, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 20__ Debt SecuritiesIndenture • February 5th, 2025 • Kezar Life Sciences, Inc. • Pharmaceutical preparations • New York
INDENTURE, dated as of [•], 20__, among KEZAR LIFE SCIENCES, INC., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
NEVADA POWER COMPANY AND THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee Indenture Dated as of February 3, 2025 Subordinated Debt SecuritiesIndenture • February 5th, 2025 • Nevada Power Co • Electric services • New York
INDENTURE, dated as of February 3, 2025, between NEVADA POWER COMPANY, a corporation duly organized and existing under the laws of the State of Nevada (herein called the “Company”), having its principal office at 6226 West Sahara Avenue, Las Vegas, Nevada 89146, and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., a national banking association duly organized and existing under the laws of the United States, as Trustee (herein called the “Trustee”).
CCSC TECHNOLOGY INTERNATIONAL HOLDINGS LIMITED (the “Issuer”) AND [TRUSTEE] (the “Trustee”) INDENTURE Dated as of [●], 20[●] Senior Debt SecuritiesIndenture • February 4th, 2025 • CCSC Technology International Holdings LTD • Electric lighting & wiring equipment • New York
INDENTURE, dated as of [●], 20[●], among CCSC Technology International Holdings Limited, a Cayman Islands exempted company with limited liability (the “Company”), and [TRUSTEE], as trustee (the “Trustee”).
CCSC TECHNOLOGY INTERNATIONAL HOLDINGS LIMITED (the “Issuer”) AND [TRUSTEE] (the “Trustee”) INDENTURE Dated as of [●], 20[●] Subordinated Debt SecuritiesIndenture • February 4th, 2025 • CCSC Technology International Holdings LTD • Electric lighting & wiring equipment • New York
INDENTURE, dated as of [●], 20[●], among CCSC Technology International Holdings Limited, a Cayman Islands exempted company with limited liability (the “Company”), and [TRUSTEE], as trustee (the “Trustee”).
ARS Pharmaceuticals, Inc., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 20__ Debt SecuritiesIndenture • January 31st, 2025 • ARS Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
INDENTURE, dated as of [•], 20__, among ARS PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
BANK OF MARIN BANCORP Issuer and Trustee INDENTURE Dated as of [ ] SENIOR DEBT SECURITIESIndenture • January 27th, 2025 • Bank of Marin Bancorp • State commercial banks • New York
Trust Indenture Act Section Indenture Section §310(a)(1) 604 (a)(2) 604 (a)(3) Not Applicabl (a)(4) Not Applicabl (b) 604; 60 §311(a) 611 (b) 611 §312(a) 703; 70 (b) 704 (c) 704 §313(a) 701 (b) 701 (c) 701 (d) 701 §314(a) 702 (a)(4) 1007 (b) Not Applicabl (c)(1) 102 (c)(2) 102 (c)(3) Not Applicabl (d) Not Applicabl (e) 102 §315(a) 601, 60 (b) 602 (c) 601 (d) 601 (e) 508 §316(a) 101 (a)(1)(A) 502; 50 (a)(1)(B) 506 (a)(2) Not Applicabl (b) 507 (c) 104 §317(a)(1) 503 (a)(2) 504 (b) 1003 §318(a) 107
BANK OF MARIN BANCORP Issuer and Trustee INDENTURE Dated as of [ ] SUBORDINATED DEBT SECURITIESIndenture • January 27th, 2025 • Bank of Marin Bancorp • State commercial banks • New York
INDENTURE dated as of ___________, between Bank of Marin Bancorp, a California corporation (the “Company”), having its principal office at 504 Redwood Boulevard, Suite 100, Novato, California 94947, and ___________ as trustee (the “Trustee”), having its principal office at ___________.
MOBIX LABS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [●], 20[●] Subordinated Debt SecuritiesIndenture • January 17th, 2025 • Mobix Labs, Inc • Semiconductors & related devices • Delaware
WHEREAS, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of subordinated debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;